Synthesis and biological evaluation of novel 3-substituted amino-4-hydroxylcoumarin derivatives as chitin synthase inhibitors and antifungal agents. 2016

Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
a Key Laboratory of Applied Chemistry of Chongqing Municipality , School of Chemistry and Chemical Engineering, Southwest University , Chongqing , PR China and.

A series of novel 3-substituted amino-4-hydroxycoumarin derivatives have been designed and synthesized as chitin synthase (CHS) inhibitors. All the synthesized compounds have been screened for their CHS inhibition activity and antimicrobial activity in vitro. The enzymatic assay indicated that most of the compounds have good inhibitory activity against CHS, in which compound 6o with IC50 of 0.10 mmol/L had stronger activity than that of polyoxins B, which acts as control drug with IC50 of 0.18 mmol/L. As far as the antifungal activity is concerned, most of the compounds possessed moderate to excellent activity against some representative pathogenic fungi. Especially, compound 6b was found to be the most potent agent against Cryptococcus neoformans with minimal inhibitory concentration (MIC) of 4 μg/mL. Moreover, the results of antibacterial screening showed that these compounds have negligible actions to some tested bacteria. Therefore, these compounds would be promising to develop selective antifungal agents.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002687 Chitin Synthase An enzyme that converts UDP glucosamine into chitin and UDP. EC 2.4.1.16. Chitin-UDP Acetylglucosaminyltransferase,Chitin Synthase 1,Chitin Synthetase 2,trans-N-Acetylglucosaminosylase,Acetylglucosaminyltransferase, Chitin-UDP,Chitin UDP Acetylglucosaminyltransferase,trans N Acetylglucosaminosylase
D003455 Cryptococcus neoformans A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans. Blastomyces neoformans,Debaryomyces neoformans,Filobasidiella neoformans,Lipomyces neoformans,Saccharomyces neoformans,Torula neoformans,Torulopsis neoformans,Cryptococcus neoformans var. grubii
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015110 4-Hydroxycoumarins Substances found in many plants, containing the 4-hydroxycoumarin radical. They interfere with vitamin K and the blood clotting mechanism, are tightly protein-bound, inhibit mitochondrial and microsomal enzymes, and are used as oral anticoagulants. 4 Hydroxycoumarins
D060326 Chemistry Techniques, Synthetic Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs. Inorganic Synthesis,Inorganic Synthesis Methods,Inorganic Synthesis Techniques,Methods of Inorganic Synthesis,Methods of Organic Synthesis,Methods of Peptide Synthesis,Organic Synthesis,Organic Synthesis Methods,Organic Synthesis Techniques,Peptide Synthesis Methods,Peptide Synthesis Techniques,Peptide Synthesis, Synthetic,Synthetic Chemistry Techniques,Synthetic Peptide Synthesis,Chemistry Technique, Synthetic,Inorganic Syntheses,Inorganic Synthesis Method,Inorganic Synthesis Technique,Method, Inorganic Synthesis,Method, Organic Synthesis,Method, Peptide Synthesis,Methods, Inorganic Synthesis,Methods, Organic Synthesis,Methods, Peptide Synthesis,Organic Syntheses,Organic Synthesis Technique,Peptide Syntheses, Synthetic,Peptide Synthesis Method,Peptide Synthesis Technique,Syntheses, Inorganic,Syntheses, Organic,Syntheses, Synthetic Peptide,Synthesis Method, Inorganic,Synthesis Method, Peptide,Synthesis Methods, Inorganic,Synthesis Methods, Peptide,Synthesis Technique, Inorganic,Synthesis Technique, Organic,Synthesis Technique, Peptide,Synthesis Techniques, Inorganic,Synthesis Techniques, Organic,Synthesis Techniques, Peptide,Synthesis, Inorganic,Synthesis, Organic,Synthesis, Synthetic Peptide,Synthetic Chemistry Technique,Synthetic Peptide Syntheses,Technique, Inorganic Synthesis,Technique, Organic Synthesis,Technique, Peptide Synthesis,Technique, Synthetic Chemistry,Techniques, Inorganic Synthesis,Techniques, Organic Synthesis,Techniques, Peptide Synthesis,Techniques, Synthetic Chemistry

Related Publications

Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
July 2023, European journal of medicinal chemistry,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
September 2021, Bioorganic chemistry,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
December 2022, European journal of medicinal chemistry,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
June 2020, European journal of medicinal chemistry,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
November 2019, European journal of medicinal chemistry,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
April 2022, European journal of medicinal chemistry,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
February 2013, Mini reviews in medicinal chemistry,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
October 2019, European journal of medicinal chemistry,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
February 2017, Bioorganic & medicinal chemistry letters,
Zhiqiang Ge, and Qinggang Ji, and Chunyan Chen, and Qin Liao, and Hualong Wu, and Xiaofei Liu, and Yanrong Huang, and Lvjiang Yuan, and Fei Liao
November 2023, European journal of medicinal chemistry,
Copied contents to your clipboard!